Skip to content
Review Open access

IRRITABLE BOWEL SYNDROME IN CHILDREN: PATHOGENESIS, DIAGNOSIS, AND MANAGEMENT

Aug 2026 · Archiv Euromedica · 0 citations

TL;DR

This narrative review summarizes current evidence on the pathogenesis, diagnosis, and long term management of pediatric IBS, with emphasis on gut brain interactions, psychosocial factors, recent pediatric guidelines, and pharmacological and non-pharmacological interventions.

Abstract

Background Irritable bowel syndrome (IBS) is a chronic disorder of gut brain interaction in children associated with recurrent abdominal pain, altered bowel habits, psychological comorbidities, impaired daily functioning, and reduced quality of life. Aim This narrative review summarizes current evidence on the pathogenesis, diagnosis, and long term management of pediatric IBS, with emphasis on gut brain interactions, psychosocial factors, recent pediatric guidelines, and pharmacological and non-pharmacological interventions. Materials and Methods PubMed, Embase, Cochrane Library, and Google Scholar were searched for English language publications from 2010 to 2026. The final search was conducted on June 15, 2026. Fifty studies and guidelines were included in the descriptive synthesis. Results Pediatric IBS has a multifactorial pathogenesis involving disturbances in gut brain communication, visceral hypersensitivity, post infectious mechanisms, alterations in the intestinal microbiota, and psychosocial factors. Diagnosis relies on symptom-based criteria, clinical assessment, and evaluation for alarm features; routine extensive testing is discouraged when alarm features are absent. Management should be individualized and may include education of the child and family, dietary measures, psychological interventions, and symptom directed pharmacotherapy. Cognitive behavioural therapy and gut directed hypnotherapy may reduce symptoms and psychological distress in selected children. Evidence for dietary and pharmacological interventions remains heterogeneous, and microbiome profiles are not established diagnostic biomarkers for routine clinical use. Conclusions Pediatric IBS should be diagnosed clinically and managed according to predominant symptoms, disease severity, psychological comorbidities, and daily functioning. Further pediatric studies are needed to clarify the effectiveness, safety, duration, and optimal sequence of interventions.

Read PDF

Similar papers

Open access Aug 2026

Clinical and extra-intestinal factors associated with irritable bowel syndrome: A case-control study.

BACKGROUND Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder. Its pathophysiology remains incompletely understood, and no objective diagnostic markers are currently available. Diagnosis is based on the Rome IV criteria, which rely exclusively on gastrointestinal symptoms and may be...

M. Gros, B. Gros-Bañeres, J. Mesonero et al. · 0 citations
Review Open access Sep 2026

Rome Criteria for irritable bowel syndrome, fifth revision: Key updates. A review

The Rome V Criteria, published in 2026, updates the scientific and clinical understanding of irritable bowel syndrome (IBS). It redefines IBS from a “functional disorder” to a “gut-brain interaction disorder,” emphasizing biological underpinnings. Recognized pathophysiological mechanisms include impaired motility, alte...

Tatiana B. Topchii, M. Ardatskaya, L. N. Maslovskii et al. · 0 citations
Review Aug 2026

What is new in abdominal pain-related disorders of the gut-brain interaction in children.

Advances in diagnostic approaches, the understanding of prevalence and pathophysiology, and growing evidence for both pharmacologic and nonpharmacologic therapies for AP-DGBI may improve future management may improve future management.

Lily Barash, Carmen Lindmoen, Rachel E. Borlack · 0 citations
Review Open access Aug 2026

Irritable Bowel Syndrome (IBS) and its management by the Unani System of Medicine: A Review

Background: Irritable Bowel Syndrome (IBS) is a functional gastrointestinal condition that is very common, relapses frequently, and severely lowers a patient's quality of life. IBS is still a treatment issue in contemporary gastroenterology. It is characterized by stomach pain, bloating, and changed bowel habits withou...

Faiyaz Ahmad, V. Singh, Amreen Fatima et al. · 0 citations
Review Open access Sep 2026

Functional Dyspepsia in Clinical Practice Current Recommendations and Future Perspectives

The evolving understanding of FD supports a shift from empirical symptom-based treatment toward individualized, mechanism-informed care, and emerging approaches targeting the duodenal microenvironment, epithelial barrier, gut microbiota, and gut–brain axis are promising.

H. Bednarz, Magdalena Mortka, Gabriela Piotrowska et al. · 0 citations
Review Sep 2026

Pharmacotherapy of Irritable Bowel Syndrome with Constipation in Children: An Update on Clinical Progress and Successes

Traditional treatments such as dietary fiber, probiotics, antispasmodics, laxatives, laxatives, prokinetics, antidepressants, antibiotics, and antihistamines are reviewed, emphasizing the limited and often inconsistent evidence supporting their use for pain relief and overall symptom improvement.

M. G. Puoti, A. Oorthuys, N. K. Vermeijden et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.